Search

Displaying results 5101 - 5110 of 5925 in total
  1. Drug

    Leptazoline A

    go.drugbank.com/drugs/DB15551
    Experimental

    Also see [Leptazoline B], [Leptazoline C], and [Leptazoline D].

  2. Drug

    Leptazoline B

    go.drugbank.com/drugs/DB15552
    Experimental

    Also see [Leptazoline A], [Leptazoline C], and [Leptazoline D].

  3. Drug

    Leptazoline C

    go.drugbank.com/drugs/DB15553
    Experimental

    Also see [Leptazoline A], [Leptazoline B], and [Leptazoline D].

  4. Drug

    Fennel

    go.drugbank.com/drugs/DB15615
    Approved

    Categories: Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors
  5. Drug

    Fenchone

    go.drugbank.com/drugs/DB15918
    Investigational

    Synonyms: DL-FenchoneCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2A6 Substrates
  6. Drug

    Vicagrel

    go.drugbank.com/drugs/DB16349
    Investigational

    Vicagrel is under investigation in clinical trial NCT03599284 (The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel).

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C19 Substrates
  7. Drug

    Azvudine

    go.drugbank.com/drugs/DB16407
    Investigational

    Azvudine is under investigation in clinical trial NCT04668235 (Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (Sars-cov-2 Infected)).

  8. Drug

    Prolectin-M

    go.drugbank.com/drugs/DB16521
    Investigational

    Prolectin-M is a (1-6)-alpha-D-mannopyranose[L31338] and acts as an antagonist of galectin.

  9. Drug

    Goldenseal

    go.drugbank.com/drugs/DB16594
    Approved

    Categories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors
  10. Drug

    Rhodamine B

    go.drugbank.com/drugs/DB16853
    Experimental

    Categories: P-glycoprotein substrates